XETRA - Delayed Quote EUR

Gerresheimer AG (GXI.DE)

100.50 +1.30 (+1.31%)
At close: April 26 at 5:41 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Dietmar Siemssen CEO, Chairman of the Management Board and CEO of Plastics, Devices & Advanced Technologies Division 2.17M -- 1963
Dr. Bernd Metzner Ph.D. CFO & Member of the Management Board 1.31M -- 1970
Dr. Lukas Burkhardt Member of the Management Board 1.28M -- 1979
Ms. Katja Schnitzler Global Senior VP of People & Organization and Member of Supervisory Board 108k -- 1981
Mr. Guido Pickert Head of Investor Relations -- -- --
Ueli Utzinger Group Senior Director Marketing & Communication -- -- --
Ms. Carolin Nadilo Corporate Director of Investor Relations -- -- --

Gerresheimer AG

Klaus-Bungert-Strasse 4
Düsseldorf, 40468
Germany
49 211 61 81 00 https://www.gerresheimer.com
Sector: 
Healthcare
Full Time Employees: 
11,947

Description

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Corporate Governance

Gerresheimer AG’s ISS Governance QualityScore as of April 1, 2024 is 4. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 1; Compensation: 2.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Jul 11, 2024
Gerresheimer AG Earnings Call

Jun 06, 2024

Ex-Dividend Date

Related Tickers